Stock page
MDNA Life Sciences Inc (MDLS)
MDNA Life Sciences Inc is an innovative life sciences company focused on the development of liquid biopsy tests based on the mitochondrial genome. The Company has a wholly-owned subsidiary MDNA Life Sciences UK Ltd. which operates in the United Kingdom (UK). The Company is a biotech innovation company with a mission of developing a range of blood-based tests to accurately identify diseases. The Company's primary business activity consists of developing and commercializing its proprietary molecular diagnostic tests. Currently, the Company's sole source of revenue is generated in the UK by providing COVID testing services to the UK market.
Quote snapshot
$0.00
Daily change: —
ExchangeNAS
Updated2026-05-09T04:26:03.618843Z
Price chart
Price history
| Name |
|---|
| Revenue |
| Cost Of Goods Sold |
| Gross Profit |
| Gross Margin % |
| Research Development |
| Selling General Admin Expense |
| Depreciation Depletion Amortization |
| Other Operating Expense |
| Total Operating Expense |
| Operating Income |
| Operating Margin |
| Interest Income |
| Interest Expense |
| Other Income Expense |
| Other Income Minority Interest |
| Other Net Income Loss |
| Ebit |
| Ebitda |
| Ebitda Margin |
| Pretax Income |
| Tax Provision |
| Tax Rate |
| Net Income Continuing Operations |
| Net Income Discontinued Operations |
| Net Income |
| Net Income Including Noncontrolling Interests |
| Is Preferred Dividends |
| Shares Outstanding |
| Eps Basic |
| Eps Diluted |
| Net Margin |
SEC filings
Latest 10-K filing table
| Date | Form | Accession | Link |
|---|